Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Neda, Stjepanovic"'
Autor:
Sun Min Lim, Solange Peters, Ana Laura Ortega Granados, Gustavo dix Junqueira Pinto, Christian Sebastián Fuentes, Giuseppe Lo Russo, Michael Schenker, Jin Seok Ahn, Martin Reck, Zsolt Szijgyarto, Neda Huseinovic, Eleftherios Zografos, Elena Buss, Neda Stjepanovic, Sean O’Donnell, Filippo de Marinis
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract PERLA is a global, double-blind, parallel phase II trial (NCT04581824) comparing efficacy and safety of anti–PD-1 antibodies dostarlimab and pembrolizumab, plus chemotherapy (DCT and PCT, respectively) as first-line treatment in patients w
Externí odkaz:
https://doaj.org/article/6e906fdccdde435787415eaa66c8249f
Autor:
Neda Stjepanovic, Tracy L. Stockley, Philippe L. Bedard, Jeanna M. McCuaig, Melyssa Aronson, Spring Holter, Kara Semotiuk, Natasha B. Leighl, Raymond Jang, Monika K. Krzyzanowska, Amit M. Oza, Abha Gupta, Christine Elser, Lailah Ahmed, Lisa Wang, Suzanne Kamel-Reid, Lillian L. Siu, Raymond H. Kim
Publikováno v:
BMC Medical Genomics, Vol 11, Iss 1, Pp 1-8 (2018)
Abstract Background Matched tumor-normal sequencing, applied in precision cancer medicine, can identify unidentified germline Medically Actionable Variants (gMAVS) in cancer predisposition genes. We report patient preferences for the return of additi
Externí odkaz:
https://doaj.org/article/07d895a2cfad4f029fe9ffa65abdccc6
Autor:
Alejandro Moles-Fernández, Laura Duran-Lozano, Gemma Montalban, Sandra Bonache, Irene López-Perolio, Mireia Menéndez, Marta Santamariña, Raquel Behar, Ana Blanco, Estela Carrasco, Adrià López-Fernández, Neda Stjepanovic, Judith Balmaña, Gabriel Capellá, Marta Pineda, Ana Vega, Conxi Lázaro, Miguel de la Hoya, Orland Diez, Sara Gutiérrez-Enríquez
Publikováno v:
Frontiers in Genetics, Vol 9 (2018)
In silico tools for splicing defect prediction have a key role to assess the impact of variants of uncertain significance. Our aim was to evaluate the performance of a set of commonly used splicing in silico tools comparing the predictions against RN
Externí odkaz:
https://doaj.org/article/0dd1b8a67c754b54889553af4b2caef3
Autor:
Sonal Gandhi, Katarzyna J. Jerzak, Neda Stjepanovic, Maureen E. Trudeau, Danilo Giffoni, Anthony Lott, Dilshad Nathoo, Andrea Eisen, Ellen Warner, Alia Thawer, Rossanna C. Pezo, Maria Romero
Publikováno v:
Cancer Research. 81:PS11-20
Background: For patients with ABC being treated with CDK4/6is palliative (RT may still be necessary to metastatic sites that are symptomatic or at risk for complications. Although preclinical data suggests synergy between CDK4/6is and RT, clinical da
Autor:
Andrea Eisen, Danilo Giffoni M. M. Mata, Sonal Gandhi, Abdullah Ma Al-Humiqani, Katarzyna J. Jerzak, Alia Thawer, Maria Luisa Romero Lagunes, Rossanna C. Pezo, Faisal Sickandar, Maureen E. Trudeau, Neda Stjepanovic, Anthony Lott, Ellen Warner
Publikováno v:
Cancer Research. 81:PS10-54
Background: For Hormonal Receptor positive/HER2 negative (HR+/HER2-) metastatic Breast Cancer (mBC) the optimal treatment post-progression on a CDK4/6 inhibitor is still not defined. We aim to identify real-world patterns of systemic treatment choice
Autor:
Rossanna C. Pezo, Danilo Giffoni Mm Mata, Althea VanMassop, Neda Stjepanovic, Maureen E. Trudeau, Sonal Gandhi, Anthony Lott, Maria Romero, Katarzyna J. Jerzak, William T. Tran, Xingshan Cao, Sharon Lemon-Wong, Andrea Eisen, Ellen Warner
Publikováno v:
Cancer Research. 81:PS10-33
Background: Pathologic complete response (pCR) following neoadjuvant chemotherapy (NAC) is associated with improved survival outcomes among women with HER2 positive (HER2+) breast cancer. We aimed to analyze the clinical, pathological and molecular f
Autor:
Maureen E. Trudeau, Sonal Gandhi, Samuel Tabbarah, Rossanna C. Pezo, Karen Ott, William T. Tran, Katarzyna J. Jerzak, Ellen Warner, Sharon Lemon, Danilo Giffoni, Andrea Eisen, Kathleen I. Pritchard, Neda Stjepanovic
Publikováno v:
Cancer Research. 80:P5-08
Background: Women with locally advanced triple negative breast cancer (LA-TNBC) have a high risk of disease recurrence and are monitored clinically and with annual mammograms. High risk women, such as BRCA1/2 carriers, are additionally monitored for
Autor:
Omar S. Usmani, Sinthia Bosnic-Anticevich, Richard Dekhuijzen, Federico Lavorini, John Bell, Neda Stjepanovic, Stephanie L. Swift, Nicolas Roche
Publikováno v:
The journal of allergy and clinical immunology. In practice. 10(10)
Switching inhaler regimens can be driven by poor disease control but also by nonclinical factors, such as cost and environmental impact. The consequences of switching for nonclinical reasons are largely unclear.To systematically review the real-world
Autor:
Rafael Fernández-Delgado, Massimo Bogliolo, Jordi Surrallés, Inmaculada Pérez de Soto, Fatima Bañez, Christopher Bauser, Cristina Beléndez-Bieler, Joaquín Dopazo, Eva M. Galvez, Raquel Sáez-Villaverde, Laura Rosiñol, Antonio Molinés, José Moraleda Jimenez, Miriam Aza-Carmona, Neda Stjepanovic, Gregorio de la Mata, Núria Muñoz-Subirana, Albert Català, Juan Miguel Bergua Burgues, Maria Marín, Leonort Senent, Ines Hernadez, Cristina Diaz-Heredia, Bienvenida Argilés, A. Figuera, Judith Reina-Castillón, Estela Carrasco, Macarena Gonzalez, Marta García, José A. Casado, José Nieto, Julián Sevilla, Luis A. Pérez-Jurado, Elena Cela, Ricardo López Almaraz, Isabel Cuesta, Antonio Escudero Soto, Raquel Portugal, José Manue Vagace, Benjamín Rodríguez-Santiago, Tobias Paprotka, Isabel Badell, Inés Hernando, Raquel Hladun, Cristina Vicho, Marta Barragaño, Anna Carrió, Pia Gallano, Francisco Lendínez, José Miguel Cosuelo, Roser Pujol, Marcos López-Sánchez, Ana Ruiz-Llobet, María Tapia, Phil Ancliff, Juan Antonio Muñoz, Monica Lopez, María Luisa Antelo, Alexandra Regueiro, Alberto Valiente, F.M. Garcia, Juan A. Bueren, Paula Río, Beatriz Arrizabalaga, Ana Maria Galera-Miñarro, Maria Carmen Garcia-Pardos, Judith Balmaña, Lidia Gonzalez-Quereda
Publikováno v:
JOURNAL OF MEDICAL GENETICS
r-CIPF: Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Centro de Investigación Principe Felipe (CIPF)
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Journal of Medical Genetics
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-CIPF: Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Centro de Investigación Principe Felipe (CIPF)
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Journal of Medical Genetics
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
PurposePatients with Fanconi anaemia (FA), a rare DNA repair genetic disease, exhibit chromosome fragility, bone marrow failure, malformations and cancer susceptibility. FA molecular diagnosis is challenging since FA is caused by point mutations and
Autor:
Lídia, Feliubadaló, Adrià, López-Fernández, Marta, Pineda, Orland, Díez, Jesús, Del Valle, Sara, Gutiérrez-Enríquez, Alex, Teulé, Sara, González, Neda, Stjepanovic, Mónica, Salinas, Gabriel, Capellá, Joan, Brunet, Conxi, Lázaro, Judith, Balmaña, Angela, Velasco
Publikováno v:
International Journal of Cancer. 145:2682-2691
Multigene panels provide a powerful tool for analyzing several genes simultaneously. We evaluated the frequency of pathogenic variants (PV) in customized predefined panels according to clinical suspicion by phenotype and compared it to the yield obta